ACR Alpine Capital Research Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sysco
SYY
|
+$23.7M |
| 2 |
Walmart Inc
WMT
|
+$10.6M |
| 3 |
Merck
MRK
|
+$6.32M |
| 4 |
Humana
HUM
|
+$5.98M |
| 5 |
Intel
INTC
|
+$4.92M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DELL
DELL INC
DELL
|
+$38.6M |
| 2 |
CLMS
Calamos Asset Management, Inc.
CLMS
|
+$4.61M |
| 3 |
Vodafone
VOD
|
+$88.4K |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$56.7K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.58% |
| 2 | Technology | 20.53% |
| 3 | Financials | 16.66% |
| 4 | Consumer Staples | 15.29% |
| 5 | Industrials | 9.54% |
Similar funds
ACR Alpine Capital Research's Q4 2013 Portfolio in Review
As of Q4 2013, ACR Alpine Capital Research held 22 positions worth $496M, up 15% from $430M the previous quarter. Its ten largest holdings account for 90% of the portfolio.
ACR Alpine Capital Research deployed $23.1M of net new capital in Q4 2013, opening 2 new positions and adding to 12 existing holdings. Its largest new stake was Southern Missouri Bancorp: 17,000 shares worth $283K.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vodafone, an estimated $88.4K trimmed.
- ACR Alpine Capital Research's largest Q4 2013 buy was Southern Missouri Bancorp: 17,000 shares worth $283K.
- ACR Alpine Capital Research added most to Sysco in Q4 2013, an estimated $23.7M increase.
- ACR Alpine Capital Research's biggest Q4 2013 reduction was Vodafone, cutting an estimated $88.4K.
- ACR Alpine Capital Research fully exited DELL INC in Q4 2013, selling an estimated $38.6M.
- ACR Alpine Capital Research's ten largest holdings make up 90% of its $496M portfolio in Q4 2013.
- ACR Alpine Capital Research opened 2 new positions and closed 2 in Q4 2013.
- ACR Alpine Capital Research's portfolio value rose 15% quarter-over-quarter to $496M.
Based on ACR Alpine Capital Research's 13F filing for Q4 2013, filed 14 Feb 2014.